← All patents

US6537804B1

BCR-ABL directed compositions and uses for inhibiting Philadelphia chromesome …

University of Texas System

Abstract

The present invention provides methods for detecting and quantitating BCR-ABL gene products and other abnormal ABL gene products of Ph1-positive leukemic cells. The invention further provides methods for determining the relative number of leukemic cells compared with normal ABL cells to assess the …

University
University of Texas System
Assignee
Board Of Regents, The University Of Texas Systems
Inventor
Ralph B. Arlinghaus
Priority date
February 16, 1995
Filing date
February 16, 1996
Grant date
March 25, 2003
Publication date
March 25, 2003
Language
en
Metadata fetched
August 28, 2026 23:57